Genetic variants in peroxisome proliferator-activated receptor-γ and retinoid X receptor-α gene and type 2 diabetes risk: A case-control study of a Chinese han population

Diabetes Technology and Therapeutics

Volumn 13, Issue 2, 2011, Pages 157-164

  Lu, Ying ^a   Ye, Xinhua ^b   Cao, Yuanyuan ^a   Li, Qian ^c   Yu, Xiaofang ^a   Cheng, Jinluo ^b   Gao, Yanqin ^a   Ma, Jianhua ^c   Du, Wencong ^a   Zhou, Ling ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA;

ACCURACY; ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; DATABASES, GENETIC; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RETINOID X RECEPTOR ALPHA;

EID: 79551602025     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0122     Document Type: Article

References (20)

1. 157-164 1. Jain S, Saraf S: Type 2 diabetes mellitus: its global prevalence and therapeutic strategies. Diabetes Metab Syndr Clin Res Rev 2010;4:48-56.
2. Diabetes Atlas [press release]. International Diabetes Federation, Cape Town, South Africa, December 4, 2006.
3. Gil-Campos M, Canete R, Gil A: Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23: 963-974.
4. Neumeier M, Weigert J, Schaffler A, Schäffler A, Weiss T, Kirchner S, Laberer S, Schölmerich J, Buechler C: Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochem Biophys Res Commun 2005;334:924-929.
5. Kintscher U, Law RE: PPARg-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 2005;288:E287-E291.
6. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, French S, Mangelsdorf DJ, Sucov HM: Hepatocyte-specific mutation establishes retinoid X receptor a as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000;20:4436-4444.
7. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I: Induction of adiponectin, a fatderived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003;52:1655-1663.
8. Bouhaha R, Meyre D, Kamoun HA, Ennafaa H, Vaillant E, Sassi R, Baroudi T, Vatin V, Froguel P, Elgaaied A, Vaxillaire M: Effect of ENPP1/PC-1-K121Q and PPARgamma- Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population. Diabetes Res Clin Pract 2008;81:278-283.
9. 12→Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001;50:891-894.
10. Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, Morris AD, Palmer CN: Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 2004;47:555-558.
11. Jaziri R, Lobbens S, Aubert R, Péan F, Lahmidi S, Vaxillaire M, Porchay I, Bellili N, Tichet J, Balkau B, Froguel P, Marre M, Fumeron F; DESIR Study Group: The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 2006;55:1157-1162.
12. Tai ES, Corella D, Deurenberg-Yap M, Adiconis X, Chew SK, Tan CE, Ordovas JM: Differential effects of the C1431T and Pro12Ala PPARg gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 2004;45:674-685.
13. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clément K, Charles MA, Tauber M, Weill J, Froguel P: Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 2005;6:11.
14. Ludovico O, Pellegrini F, Di Paola R, Minenna A, Mastroianno S, Cardellini M, Marini MA, Andreozzi F, Vaccaro O, Sesti G, Trischitta V: Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. Obesity (Silver Spring) 2007;15:1076-1081.
15. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S: Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008;57:791-795.
16. Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, Hartiala J, Lehtinen AB, Haffner SM, Bergman RN, McEachin RC, Kjos SL, Lawrence JM, Buchanan TA, Watanabe RM: Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 2008;57:1048-1056.
17. Brito EC, Lyssenko V, Renström F, Berglund G, Nilsson PM, Groop L, Franks PW: Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. Diabetes 2009;58:1411-1418.
18. Wu SH, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E: Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARg and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009;24:3360-3366.
19. Liu L, Zheng T, Wang F, Wang N, Song Y, Li M, Li L, Jiang J, Zhao W: Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2010;33: 144-149.
20. Wan YJ, Han G, Cai Y, Dai T, Konishi T, Leng AS: Hepatocyte retinoid X receptor-a-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance. Endocrinology 2003;144:605-611.